Inna M. Chen

1.4k total citations
53 papers, 839 citations indexed

About

Inna M. Chen is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Inna M. Chen has authored 53 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 16 papers in Cancer Research and 10 papers in Surgery. Recurrent topics in Inna M. Chen's work include Pancreatic and Hepatic Oncology Research (36 papers), Cancer Genomics and Diagnostics (14 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Inna M. Chen is often cited by papers focused on Pancreatic and Hepatic Oncology Research (36 papers), Cancer Genomics and Diagnostics (14 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Inna M. Chen collaborates with scholars based in Denmark, United States and Norway. Inna M. Chen's co-authors include Dorte Nielsen, Julia S. Johansen, Anne Dyhl-Polk, Ole Haagen Nielsen, Benny Vittrup Jensen, Astrid Z. Johansen, Carsten Palnæs Hansen, Susann Theile, Carsten Bogh Juhl and M.A. Karsdal and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Inna M. Chen

50 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Inna M. Chen Denmark	16	583	171	161	152	148	53	839
Chara Stavraka United Kingdom	16	322 0.6×	229 1.3×	128 0.8×	106 0.7×	118 0.8×	45	755
Lara Alessandrini Italy	17	284 0.5×	217 1.3×	82 0.5×	163 1.1×	199 1.3×	69	827
Junzhou Wu China	15	321 0.6×	201 1.2×	94 0.6×	133 0.9×	176 1.2×	30	645
Joo Han Lim South Korea	18	393 0.7×	335 2.0×	69 0.4×	163 1.1×	144 1.0×	61	867
Małgorzata Fuksiewicz Poland	14	321 0.6×	170 1.0×	178 1.1×	81 0.5×	70 0.5×	42	620
Ik‐Chan Song South Korea	17	208 0.4×	236 1.4×	139 0.9×	89 0.6×	80 0.5×	87	720
Jennifer L. Miller-Ocuin United States	10	250 0.4×	252 1.5×	247 1.5×	95 0.6×	83 0.6×	23	703
Yvette C. Tanhehco United States	13	553 0.9×	410 2.4×	158 1.0×	102 0.7×	47 0.3×	49	1.1k
Vera Schellerer Germany	20	550 0.9×	265 1.5×	142 0.9×	160 1.1×	270 1.8×	60	1.1k

Countries citing papers authored by Inna M. Chen

Since Specialization

Citations

This map shows the geographic impact of Inna M. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inna M. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inna M. Chen more than expected).

Fields of papers citing papers by Inna M. Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inna M. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inna M. Chen. The network helps show where Inna M. Chen may publish in the future.

Co-authorship network of co-authors of Inna M. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Inna M. Chen. A scholar is included among the top collaborators of Inna M. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inna M. Chen. Inna M. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hruban, Carolyn, Daniel C. Bruhm, Inna M. Chen, et al.. (2025). Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer. Science Advances. 11(21). eads5002–eads5002. 3 indexed citations

Chen, Inna M., Julia S. Johansen, Susann Theile, et al.. (2025). Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia. Journal of Clinical Oncology. 43(18). 2107–2118. 8 indexed citations

Chen, Inna M., Julia S. Johansen, Rikke Fredslund Andersen, et al.. (2025). The Prognostic Impact of Early ctDNA Kinetics in Metastatic Pancreatic Cancer Using the ctDNA-RECIST. Clinical Cancer Research. 31(22). 4720–4729.

Khan, Shawez, Majken Siersbæk, Julie Westerlin Kjeldsen, et al.. (2024). The antitumor activity of TGFβ-specific T cells is dependent on IL-6 signaling. Cellular and Molecular Immunology. 22(1). 111–126. 5 indexed citations

Johansen, Julia S., Finn Ole Larsen, Susann Theile, et al.. (2024). Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study. Clinical Cancer Research. 30(16). 3428–3437. 3 indexed citations

Winther, Stine Brændegaard, Inna M. Chen, Britta Weber, et al.. (2023). A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01). BMC Cancer. 23(1). 552–552. 1 indexed citations

Hjaltelin, Jessica Xin, Isabella Friis Jørgensen, David Westergaard, et al.. (2023). Pancreatic cancer symptom trajectories from Danish registry data and free text in electronic health records. eLife. 12. 2 indexed citations

Madsen, Kasper, Astrid Z. Johansen, Inna M. Chen, et al.. (2023). Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma. Cancers. 15(3). 897–897. 4 indexed citations

Madsen, Kasper, Ole Larsen, Lars Henrik Jensen, et al.. (2023). Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer. Cancers. 15(4). 1062–1062. 6 indexed citations

10.

Nissen, Neel I., Astrid Z. Johansen, Inna M. Chen, et al.. (2023). High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients with pancreatic ductal adenocarcinoma. Frontiers in Molecular Biosciences. 10. 1158058–1158058. 5 indexed citations

11.

Holmström, Morten Orebo, Jane Preuss Hasselby, Gro Linno Willemoe, et al.. (2023). Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy. Journal for ImmunoTherapy of Cancer. 11(3). e006432–e006432. 11 indexed citations

12.

Johansen, Astrid Z., Jessica Xin Hjaltelin, Susann Theile, et al.. (2023). Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy. Frontiers in Immunology. 14. 1228907–1228907. 5 indexed citations

13.

Chen, Inna M., Julia S. Johansen, Susann Theile, et al.. (2022). Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC). Journal of Clinical Oncology. 40(27). 3180–3189. 68 indexed citations

14.

Pedersen, Rasmus S., Neel I. Nissen, Christina Jensen, et al.. (2022). Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibrogenesis. Biomolecules. 12(9). 1315–1315. 7 indexed citations

15.

Nissen, Neel I., Christina Jensen, Inna M. Chen, et al.. (2022). Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic Cancer. Cells. 11(23). 3763–3763. 17 indexed citations

16.

Jensen, Kristian K., Jan Henrik Storkholm, Inna M. Chen, Stefan Kobbelgaard Burgdorf, & Carsten Palnæs Hansen. (2022). Long-term results after resection of primary duodenal adenocarcinoma: A retrospective cohort study. International Journal of Surgery. 100. 106599–106599. 8 indexed citations

17.

Sztupinszki, Zsófia, Inna M. Chen, Astrid Z. Johansen, et al.. (2021). Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification. Clinical Cancer Research. 27(9). 2592–2603. 22 indexed citations

18.

Burgdorf, Stefan Kobbelgaard, et al.. (2021). Postoperative and long-term survival in relation to life-expectancy after pancreatic surgery in elderly patients (cohort study). Annals of Medicine and Surgery. 69. 102724–102724. 2 indexed citations

19.

Chen, Inna M., Astrid Z. Johansen, Christian Dehlendorff, et al.. (2019). Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer. Cancer Epidemiology Biomarkers & Prevention. 29(1). 176–184. 12 indexed citations

20.

Dyhl-Polk, Anne, et al.. (2019). Checkpoint inhibitors in pancreatic cancer. Cancer Treatment Reviews. 78. 17–30. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact